Cargando…

Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule

We investigated whether carboplatin pharmacokinetics is altered when the drug is delivered daily over 5 days, compared to a single‐day infusion. Carboplatin was infused in 11 patients with lung cancer, who were randomly assigned to 2 groups. In the first group, the agent was administered on a conven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ando, Yuichi, Minami, Hironobu, Saka, Hideo, Ando, Masahiko, Sugiura, Seiji, Sakai, Shuzo, Shimokata, Kaoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921454/ https://www.ncbi.nlm.nih.gov/pubmed/9247610 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00412.x

Ejemplares similares

Therapeutic Drug Monitoring in 21‐Day Oral Etoposide Treatment for Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996)

Therapeutic Drug Monitoring of Etoposide in a 14‐Day Infusion for Non‐small‐cell Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996)

Prognostic Factors for Short‐term Survival in Patients with Stage IV Non‐small Cell Lung Cancer
por: Ando, Masahiko, et al.
Publicado: (1999)

Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
por: Ando, Y., et al.
Publicado: (1997)

CARBOPLATIN DOSING FOR ADULT JAPANESE PATIENTS
por: ANDO, YUICHI, et al.
Publicado: (2014)

Genetic Polymorphisms of the UDP‐Glucuronosyltransferase 1A7 Gene and Irinotecan Toxicity in Japanese Cancer Patients
por: Ando, Maki, et al.
Publicado: (2002)

Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer
por: Hatta, Takahiro, et al.
Publicado: (2023)

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
por: Ando, M, et al.
Publicado: (2001)

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule
por: Awada, A, et al.
Publicado: (1999)

Hearing impairment risk and interaction of folate metabolism related gene polymorphisms in an aging study
por: Uchida, Yasue, et al.
Publicado: (2011)

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.
por: Mulder, P. O., et al.
Publicado: (1990)

Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer
por: Yumuk, Perran F, et al.
Publicado: (2005)

Seizures after intravenous tramadol given as premedication
por: Raiger, Lalit Kumar, et al.
Publicado: (2012)

The association between hearing impairment and polymorphisms of genes encoding inflammatory mediators in Japanese aged population
por: Uchida, Yasue, et al.
Publicado: (2014)

Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies
por: Minami, Hironobu, et al.
Publicado: (2020)

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma
por: Tomono, Ayana, et al.
Publicado: (2016)

Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
por: Miya, Toshimichi, et al.
Publicado: (2016)

A phase I and pharmacokinetic study of indisulam in combination with carboplatin
por: Dittrich, C, et al.
Publicado: (2007)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993)

Comparative Pharmacokinetics and Allometric Scaling of Carboplatin in Different Avian Species
por: Antonissen, Gunther, et al.
Publicado: (2015)

Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
por: Avedissian, Sean N., et al.
Publicado: (2021)

Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma
por: Okuni, Marika, et al.
Publicado: (2018)

A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer
por: Hasegawa, Kosei, et al.
Publicado: (2020)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
por: English, M. W., et al.
Publicado: (1996)

Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice.
por: Korst, A. E., et al.
Publicado: (1997)

Welcome, project overview and schedule for the day
por: JONES, Bob
Publicado: (2016)

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
por: Yonemori, K, et al.
Publicado: (2009)

Dietary Supplement Use by Community-living Population in Japan: Data from the National Institute for Longevity Sciences Longitudinal Study of Aging (NILS-LSA)
por: Imai, Tomoko, et al.
Publicado: (2006)

The Longitudinal Impact of Hearing Impairment on Cognition Differs According to Cognitive Domain
por: Uchida, Yasue, et al.
Publicado: (2016)

Serum concentration and safety of intravenous drip versus subcutaneous administration of carboplatin in dogs
por: IWANO, Masataka, et al.
Publicado: (2021)

Impact of indoor temperature instability on diurnal and day-by-day variability of home blood pressure in winter: a nationwide Smart Wellness Housing survey in Japan
por: Umishio, Wataru, et al.
Publicado: (2021)

Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
por: Kamitani, Rei, et al.
Publicado: (2022)

The effect on post-operative pain of intravenous clonidine given before induction of anaesthesia
por: Samantaray, Aloka, et al.
Publicado: (2012)

Dose Schedule Optimization and the Pharmacokinetic Driver of Neutropenia
por: Patel, Mayankbhai, et al.
Publicado: (2014)

Chemotherapy for biliary tract cancer: real-world experience in a single institute
por: Maeda, Osamu, et al.
Publicado: (2020)

Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
por: Heijns, Joan B., et al.
Publicado: (2008)

A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer.
por: Siddiqui, N., et al.
Publicado: (1997)

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis
por: Nijstad, A. Laura, et al.
Publicado: (2020)

Pharmacokinetics of Carboplatin in Combination with Low-Dose Cyclophosphamide in Female Dogs with Mammary Carcinoma
por: Machado, Marília Carneiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s5kstofjchj0fvp01p0uu7qlaa